These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33515520)

  • 1. Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes - Authors' reply.
    Agudelo CI; Castañeda-Orjuela C; Di Fabio JL; Castañeda E
    Lancet Infect Dis; 2021 Feb; 21(2):171-172. PubMed ID: 33515520
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes.
    Theilacker C; Fletcher MA; Spinardi JR; Jodar L; Gessner BD
    Lancet Infect Dis; 2021 Feb; 21(2):170-171. PubMed ID: 33515518
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease - Authors' reply.
    de Cunto Brandileone MC; Castañeda-Orjuela C; Almeida SCG; Andrade AL
    Lancet Infect Dis; 2021 Apr; 21(4):453-454. PubMed ID: 33773124
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study.
    Desmet S; Lagrou K; Wyndham-Thomas C; Braeye T; Verhaegen J; Maes P; Fieuws S; Peetermans WE; Blumental S
    Lancet Infect Dis; 2021 Jan; 21(1):127-136. PubMed ID: 32702303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean.
    Whitney CG; Toscano CM
    Lancet Infect Dis; 2021 Mar; 21(3):306-308. PubMed ID: 32986995
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
    Guevara JN; Izurieta P; Hoet B
    Expert Rev Vaccines; 2018 Apr; 17(4):283-284. PubMed ID: 29611439
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease.
    Camargos P; Drumond E; Nascimento-Carvalho CM
    Lancet Infect Dis; 2021 Apr; 21(4):453. PubMed ID: 33773123
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong.
    Wu DB; Roberts C; Lee VW; Hong LW; Tan KK; Mak V; Lee KK
    Hum Vaccin Immunother; 2016; 12(2):403-16. PubMed ID: 26451658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis.
    Sinha A; Constenla D; Valencia JE; O'Loughlin R; Gomez E; de la Hoz F; Valenzuela MT; de Quadros CA
    Rev Panam Salud Publica; 2008 Nov; 24(5):304-13. PubMed ID: 19141172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
    Temple B; Toan NT; Dai VTT; Bright K; Licciardi PV; Marimla RA; Nguyen CD; Uyen DY; Balloch A; Huu TN; Mulholland EK
    Lancet Infect Dis; 2019 May; 19(5):497-509. PubMed ID: 30975525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand.
    Dilokthornsakul P; Kengkla K; Saokaew S; Permsuwan U; Techasaensiri C; Chotpitayasunondh T; Chaiyakunapruk N
    Vaccine; 2019 Jul; 37(32):4551-4560. PubMed ID: 31280944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.
    Hanquet G; Krizova P; Valentiner-Branth P; Ladhani SN; Nuorti JP; Lepoutre A; Mereckiene J; Knol M; Winje BA; Ciruela P; Ordobas M; Guevara M; McDonald E; Morfeldt E; Kozakova J; Slotved HC; Fry NK; Rinta-Kokko H; Varon E; Corcoran M; van der Ende A; Vestrheim DF; Munoz-Almagro C; Latasa P; Castilla J; Smith A; Henriques-Normark B; Whittaker R; Pastore Celentano L; Savulescu C;
    Thorax; 2019 May; 74(5):473-482. PubMed ID: 30355641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.
    Tin Tin Htar M; van Den Biggelaar AHJ; Sings H; Ferreira G; Moffatt M; Hall-Murray C; Verstraeten T; Gessner BD; Schmitt HJ; Jodar L
    Expert Rev Vaccines; 2019 Oct; 18(10):1069-1089. PubMed ID: 31585049
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.
    Gidding HF; Sheridan S; Fathima P; Moore HC; Liu B; McIntyre PB; Palmu AA;
    Pediatr Infect Dis J; 2019 Aug; 38(8):860-865. PubMed ID: 30985507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.
    Wouters I; Desmet S; Van Heirstraeten L; Blaizot S; Verhaegen J; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2019 Feb; 37(8):1080-1086. PubMed ID: 30665775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
    Abu Seir R; Azmi K; Hamdan A; Namouz H; Jaar F; Jaber H; Rubin C; Doron D; Rahav G; Abdeen Z; Regev-Yochay G
    PLoS One; 2018; 13(11):e0206927. PubMed ID: 30418989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological burden of invasive pneumococcal disease in children and adolescents with predisposing risk factors.
    Falleiros-Arlant LH; Berezin EN; Avila-Aguero ML; Pirez MC; Gentile A; Richardson V; Brea J; Mariño C
    Int J Infect Dis; 2015 Sep; 38():1-6. PubMed ID: 26135848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.
    de Oliveira LH; Trumbo SP; Ruiz Matus C; Sanwogou NJ; Toscano CM
    Expert Rev Vaccines; 2016 Oct; 15(10):1295-304. PubMed ID: 26982434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.